Drug Studies

- MiFlaPro - multicentre phase III AMG study on drug treatment of chronic haemorrhagic radiation proctitis (Med. Univ. Innsbruck, 12 centres Austria-wide) - recruitment of subjects since February 2020 in 12 Austrian centres.
>> More information

- ChINOREC - multicentre phase II AMG study on neoadjuvant chemoradiotherapy with sequential ipilimumab & nivolumab in rectal cancer (Med. Univ. Vienna, national) - currently centre recruitment
>> More information